Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) hit a new 52-week high on Wednesday . The stock traded as high as $139.88 and last traded at $139.59, with a volume of 3270123 shares trading hands. The stock had previously closed at $135.34.
SPDR S&P Biotech ETF Stock Performance
The company has a market capitalization of $8.98 billion, a PE ratio of 11.47 and a beta of 0.85. The stock’s fifty day simple moving average is $133.36 and its 200-day simple moving average is $127.61.
Hedge Funds Weigh In On SPDR S&P Biotech ETF
Institutional investors and hedge funds have recently modified their holdings of the company. Bank of America Corp DE grew its stake in SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after acquiring an additional 1,700,851 shares during the period. Morgan Stanley lifted its stake in shares of SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after purchasing an additional 882,718 shares during the period. Wells Fargo & Company MN lifted its stake in shares of SPDR S&P Biotech ETF by 75.7% during the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after purchasing an additional 1,536,122 shares during the period. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $256,053,000. Finally, Bessemer Group Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 13.5% during the fourth quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock worth $225,965,000 after purchasing an additional 220,244 shares during the last quarter.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
